Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024
05 Gennaio 2024 - 2:00PM
Business Wire
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest
pure-play consumer health company by revenue, will announce its
financial results for the fourth quarter and full year ending
December 31, 2023, before market open on February 8, 2024.
The company will host a conference call and webcast at 8:30 a.m.
Eastern Time to discuss the financial results. The conference call
can be accessed by dialing 888-660-5501 from the U.S. or
646-960-0416 from international locations. The conference ID for
all callers is 1558006. A live webcast of the conference call will
be available at https://investors.kenvue.com. A replay will be
available approximately two hours after the live event.
About Kenvue
Kenvue is the world’s largest pure-play consumer health company
by revenue. Built on more than a century of heritage, our iconic
brands, including Aveeno®, BAND-AID® Brand Adhesive Bandages,
Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are
science-backed and recommended by healthcare professionals around
the world. At Kenvue, we believe in the extraordinary power of
everyday care and our teams work every day to put that power in
consumers’ hands and earn a place in their hearts and homes. Learn
more at www.kenvue.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240104331874/en/
Investor Relations: Tina Romani Kenvue_IR@kenvue.com
Media Relations: Melissa Witt media@kenvue.com
Grafico Azioni Kenvue (NYSE:KVUE)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Kenvue (NYSE:KVUE)
Storico
Da Giu 2023 a Giu 2024